Results 91 to 100 of about 12,480 (212)

Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020. [PDF]

open access: yesEuro Surveill, 2022
Debin M   +11 more
europepmc   +1 more source

Seroprevalence of IgA and IgM antibodies to Bordetella pertussis in healthy Japanese donors: Assessment for the serological diagnosis of pertussis.

open access: yesPLoS ONE, 2019
Pertussis is a human respiratory infection caused by the gram-negative bacterium, Bordetella pertussis. To evaluate the pertussis burden and vaccine efficacy, diagnosis and epidemiological surveillance should be based on accurate and valid diagnostic ...
Rei Fumimoto   +6 more
doaj   +1 more source

Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China.

open access: yesPLoS ONE, 2016
BackgroundThe resurgence of pertussis has occurred in many countries. However, the epidemiological profiles of pertussis cannot be well understood by the current surveillance system in China.
Hanqing He   +4 more
doaj   +1 more source

Pertussis surveillance 1989-1995

open access: yes, 1996
The incidence of pertussis in the Netherlands in 1989-1995 was estimated from notifications by law, hospital admissions, positive serodiagnostics (positive one-point serology and positive two-point serology) and isolations of Bordetella. After the epidemic peak in 1994 the incidence of pertussis decreased in 1995 (notifications 3.4 versus 2.2/100,000).
Melker HE de   +2 more
openaire   +1 more source

Paediatric surveillance of pertussis in 1998

open access: yes, 2000
Objective: To gain insight into the severity of pertussis in hospitalised cases. Methods: In 1998, hospitalisation data were collected through paediatric surveillance. Results: From 115 hospitalisation admissions collected, 55% of the patients were younger than 3 months of age and not vaccinated; 12% were 3-5 months of age and of these, 50% were ...
Melker HE de   +4 more
openaire   +1 more source

Positivity analysis of Bordetella spp. and SARS-CoV-2 coinfections in clinical samples from Colombia, 2021–2022

open access: yesMicrobiology Spectrum
Pertussis and COVID-19 are respiratory diseases with similar clinical manifestations, complicating diagnosis. In Colombia, pertussis surveillance is based on probable cases confirmed through laboratory detection of Bordetella pertussis.
Valentina Bonilla-Bravo   +11 more
doaj   +1 more source

Pertussis: (Week 07) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending February 18, 2023

open access: yes
Pertussis cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by ...

core  

Pertussis: (Week 27) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 8, 2023

open access: yes
Pertussis cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by ...

core  

How to improve pertussis vaccination in pregnancy: a European expert review

open access: yesExpert Review of Vaccines
Introduction Pertussis vaccination in pregnancy is a safe and highly effective strategy to protect young infants against severe pertussis, but cases continue to occur.
Adam Finn   +8 more
doaj   +1 more source

Pertussis: (Week 29) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 22, 2023

open access: yes
Pertussis cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations. Healthcare providers, medical labs, and other entities report conditions to public health departments, varying by ...

core  

Home - About - Disclaimer - Privacy